Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Cash from Financing Activities (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Cash from Financing Activities over the past 9 years, most recently at -$1.9 million for Q4 2023.

  • For Q4 2023, Cash from Financing Activities fell 912.98% year-over-year to -$1.9 million; the TTM value through Dec 2023 reached -$2.8 million, down 428.66%, while the annual FY2024 figure was $166.6 million, 6004.93% up from the prior year.
  • Cash from Financing Activities for Q4 2023 was -$1.9 million at Corbus Pharmaceuticals Holdings, down from -$821000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $60.4 million in Q1 2021 and troughed at -$1.9 million in Q4 2023.
  • A 5-year average of $12.5 million and a median of -$3319.0 in 2019 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 189696.29% in 2020 and later plummeted 912.98% in 2023.
  • Year by year, Cash from Financing Activities stood at $752658.0 in 2019, then soared by 2787.77% to $21.7 million in 2020, then crashed by 96.47% to $767938.0 in 2021, then tumbled by 69.49% to $234322.0 in 2022, then plummeted by 912.98% to -$1.9 million in 2023.
  • Business Quant data shows Cash from Financing Activities for CRBP at -$1.9 million in Q4 2023, -$821000.0 in Q3 2023, and $18010.0 in Q2 2023.